- Home
- FBIOP vs HPKEW Comparison
FBIOP vs HPKEW Comparison
Compare FBIOP & HPKEW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FBIOP
- HPKEW
- Stock Information
- Founded
- FBIOP N/A
- HPKEW 2019
- Country
- FBIOP United States
- HPKEW United States
- Employees
- FBIOP 101
- HPKEW N/A
- Industry
- FBIOP Biotechnology: Pharmaceutical Preparations
- HPKEW Oil & Gas Production
- Sector
- FBIOP Health Care
- HPKEW Energy
- Exchange
- FBIOP Nasdaq
- HPKEW Nasdaq
- Market Cap
- FBIOP N/A
- HPKEW N/A
- IPO Year
- FBIOP N/A
- HPKEW N/A
- Fundamental
- Price
- FBIOP $6.15
- HPKEW $0.69
- Analyst Decision
- FBIOP
- HPKEW
- Analyst Count
- FBIOP 0
- HPKEW 0
- Target Price
- FBIOP N/A
- HPKEW N/A
- AVG Volume (30 Days)
- FBIOP N/A
- HPKEW 4.5K
- Earning Date
- FBIOP N/A
- HPKEW 03-06-2025
- Dividend Yield
- FBIOP N/A
- HPKEW N/A
- EPS Growth
- FBIOP N/A
- HPKEW N/A
- EPS
- FBIOP N/A
- HPKEW 1.26
- Revenue
- FBIOP N/A
- HPKEW $1,135,761,000.00
- Revenue This Year
- FBIOP N/A
- HPKEW N/A
- Revenue Next Year
- FBIOP N/A
- HPKEW N/A
- P/E Ratio
- FBIOP N/A
- HPKEW $11.06
- Revenue Growth
- FBIOP N/A
- HPKEW 6.34
- 52 Week Low
- FBIOP N/A
- HPKEW $3.00
- 52 Week High
- FBIOP N/A
- HPKEW $10.80
- Technical
- Relative Strength Index (RSI)
- FBIOP 47.56
- HPKEW 35.90
- Support Level
- FBIOP $6.36
- HPKEW $0.50
- Resistance Level
- FBIOP $6.80
- HPKEW $1.07
- Average True Range (ATR)
- FBIOP 0.37
- HPKEW 0.13
- MACD
- FBIOP 0.01
- HPKEW 0.02
- Stochastic Oscillator
- FBIOP 45.52
- HPKEW 37.70
About FBIOP Fortress Biotech Inc.
Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Qbrexza, Accutane, Amzeeq, Zilxi, Targadox, Ximino, and Exelderm. The business activities of the group are functioned through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development. It derives the majority of its revenues from Dermatology segment. Its subsidiaries also operate in biotechnology, pharmaceutical, oncology and therapeutics sectors.